Chinese medical devices are in health systems across U.S., and the government and hospitals are worried
How the FDA's approval for food additives works, and why experts say a loophole allows companies to bypass it
Anne Wojcicki has a new offer to take 23andMe private, this time for $74.7 million
Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker
UnitedHealth's rough stretch continues, with buyouts, a reported DOJ probe and a 23% drop in three months
BP Life: Championing Transparency and Health with High-Purity Fenbendazole
